Clinical relevance of SKP2 alterations in metastatic melanoma

Pigment Cell and Melanoma Research

Volumn 24, Issue 1, 2011, Pages 197-206

  Rose, Amy E ^a   Wang, Guimin ^a   Hanniford, Douglas ^a   Monni, Stefano ^b   Tu, Ting ^a   Shapiro, Richard L ^a   Berman, Russell S ^a   Pavlick, Anna C ^a   Pagano, Michele ^a,c   Darvishian, Farbod ^a   Mazumdar, Madhu ^b   Hernando, Eva ^a   Osman, Iman ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Gene expression; Melanoma; Metastasis; SKP2; SNP array

Indexed keywords

MESSENGER RNA; S PHASE KINASE ASSOCIATED PROTEIN 2;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER RECURRENCE; CANCER SURVIVAL; CELL CYCLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; EVALUATION; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LOCI; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; NUCLEOTIDES; OPEN READING FRAMES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECURRENCE; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S-PHASE KINASE-ASSOCIATED PROTEINS; SURVIVAL ANALYSIS;

EID: 78651432897     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2010.00784.x     Document Type: Article

References (47)

1. Ahn, J., Hong, S., Lee, S.-E., Kim, J., Oh, Y., Park, S., and Chung, Y. (2009). Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma. Endocr. J. 56, 707-713.
2. Alonso, S.R., Ortiz, P., Pollan, M. et al. (2004). Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study. Am. J. Pathol. 164, 193-203.
3. Berger, M.F., Levin, J.Z., Vijayendran, K. et al. (2010). Integrative analysis of the melanoma transcriptome. Genome Res. 20, 413-427.
4. Bhatt, K.V., Hu, R., Spofford, L.S., and Aplin, A.E. (2007). Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells. Oncogene 26, 1056-1066.
5. Bogunovic, D., O'neill, D.W., Belitskaya-Levy, I. et al. (2009). Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proc. Natl Acad. Sci. USA 106, 20429-20434.
6. Bornstein, G., Bloom, J., Sitry-Shevah, D., Nakayama, K., Pagano, M., and Hershko, A. (2003). Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J. Biol. Chem. 278, 25752-25757.
7. Bos, P.D., Zhang, X.H., Nadal, C. et al. (2009). Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005-1009.
8. Calvisi, D., Ladu, S., Pinna, F. et al. (2009). SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis. Gastroenterology 137, 1816-1826.
9. Felicetti, F., Errico, M.C., Bottero, L. et al. (2008). The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res. 68, 2745-2754.
10. Garrett-Engele, C., Tasch, M., Hwang, H., Fero, M., Perlmutter, R., Clurman, B., and Roberts, J. (2007). A mechanism misregulating p27 in tumors discovered in a functional genomic screen. PLoS Genet. 3, e219.
11. Guttilla, I., and White, B. (2009). Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J. Biol. Chem. 284, 23204-23216.
12. Hashimoto, N., Yachida, S., Okano, K. et al. (2009). Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas. Ann. Surg. Oncol. 16, 395-403.
13. Hershko, D.D. (2008). Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer. Cancer 112, 1415-1424.
14. Hu, R., and Aplin, A. (2008). Skp2 regulates G2/M progression in a p53-dependent manner. Mol. Biol. Cell 19, 4602-4610.
15. Huang, H., Regan, K.M., Wang, F., Wang, D., Smith, D.I., Van Deursen, J.M., and Tindall, D.J. (2005). Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc. Natl Acad. Sci. USA 102, 1649-1654.
16. Kamura, T., Hara, T., Kotoshiba, S., Yada, M., Ishida, N., Imaki, H., Hatakeyama, S., Nakayama, K., and Nakayama, K. (2003). Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc. Natl Acad. Sci. USA 100, 10231-10236.
17. Katagiri, Y., Hozumi, Y., and Kondo, S. (2006). Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo. J. Dermatol. Sci. 42, 215-224.
18. Kent, W.J., Sugnet, C.W., Furey, T.S., Roskin, K.M., Pringle, T.H., Zahler, A.M., and Haussler, D. (2002). The human genome browser at UCSC. Genome Res. 12, 996-1006.
19. Korn, J.M., Kuruvilla, F.G., Mccarroll, S.A. et al. (2008). Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat. Genet. 40, 1253-1260.
20. Lee, J., and Kim, S. (2009). The function of p27 KIP1 during tumor development. Exp. Mol. Med. 41, 765-771.
21. Li, Q., Murphy, M., Ross, J., Sheehan, C., and Carlson, J.A. (2004). Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship. J. Cutan. Pathol. 31, 633-642.
22. Li, W., Sanki, A., Karim, R.Z., Thompson, J.F., Soon Lee, C., Zhuang, L., Mccarthy, S.W., and Scolyer, R.A. (2006). The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology 38, 287-301.
23. Lin, H.K., Chen, Z., Wang, G. et al. (2010). Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature 464, 374-379.
24. Lin, W.M., Baker, A.C., Beroukhim, R. et al. (2008). Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Res. 68, 664-673.
25. Ma, X.M., Liu, Y., Guo, J.W., Liu, J.H., and Zuo, L.F. (2005). Relation of overexpression of S phase kinase-associated protein 2 with reduced expression of p27 and PTEN in human gastric carcinoma. World J. Gastroenterol. 11, 6716-6721.
26. Mamillapalli, R., Gavrilova, N., Mihaylova, V.T., Tsvetkov, L.M., Wu, H., Zhang, H., and Sun, H. (2001). PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2). Curr. Biol. 11, 263-267.
27. Marti, A., Wirbelauer, C., Scheffner, M., and Krek, W. (1999). Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat. Cell Biol. 1, 14-19.
28. Mouriaux, F., Maurage, C.A., Labalette, P., Sablonniere, B., Malecaze, F., and Darbon, J.M. (2000). Cyclin-dependent kinase inhibitory protein expression in human choroidal melanoma tumors. Invest. Ophthalmol. Vis. Sci. 41, 2837-2843.
29. Osoegawa, A., Yoshino, I., Tanaka, S., Sugio, K., Kameyama, T., Yamaguchi, M., and Maehara, Y. (2004). Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer. J. Clin. Oncol. 22, 4165-4173.
30. Padua, D., Zhang, X.H., Wang, Q., Nadal, C., Gerald, W.L., Gomis, R.R., and Massague, J. (2008). TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133, 66-77.
31. Sauroja, I., Smeds, J., Vlaykova, T., Kumar, R., Talve, L., Hahka-Kemppinen, M., Punnonen, K., Jansen, C.T., Hemminki, K., and Pyrhonen, S. (2000). Analysis of G(1)/S checkpoint regulators in metastatic melanoma. Genes Chromosomes Cancer 28, 404-414.
32. Schulman, B.A., Carrano, A.C., Jeffrey, P.D., Bowen, Z., Kinnucan, E.R., Finnin, M.S., Elledge, S.J., Harper, J.W., Pagano, M., and Pavletich, N.P. (2000). Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature 408, 381-386.
33. Scott, K.L., Kabbarah, O., Liang, M.C. et al. (2009). GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature 459, 1085-1090.
34. Segura, M.F., Hanniford, D., Menendez, S. et al. (2009). Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc. Natl Acad. Sci. USA 106, 1814-1819.
35. Sherr, C.J. (1996). Cancer cell cycles. Science 274, 1672-1677.
36. Sumimoto, H., Hirata, K., Yamagata, S., Miyoshi, H., Miyagishi, M., Taira, K., and Kawakami, Y. (2006). Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi. Int. J. Cancer 118, 472-476.
37. Tichopad, A., Bar, T., Pecen, L., Kitchen, R., Kubista, M., and Pfaffl, M. (2010). Quality control for quantitative PCR based on amplification compatibility test. Methods 50, 308-312.
38. Traub, F., Mengel, M., Luck, H.J., Kreipe, H.H., and Von Wasielewski, R. (2006). Prognostic impact of Skp2 and p27 in human breast cancer. Breast Cancer Res. Treat. 99, 185-191.
39. Wang, H., Bauzon, F., Ji, P. et al. (2010). Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1 +/- mice. Nat. Genet. 42, 83-88.
40. Wich, LG, Hamilton, HK, Shapiro, RL et al. (2009). Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research. Am. J. Transl. Res. 1, 35-43.
41. Woenckhaus, C., Maile, S., Uffmann, S., Bansemir, M., Dittberner, T., Poetsch, M., and Giebel, J. (2005). Expression of Skp2 and p27KIP1 in naevi and malignant melanoma of the skin and its relation to clinical outcome. Histol. Histopathol. 20, 501-508.
42. Yeh, K.H., Kondo, T., Zheng, J., Tsvetkov, L.M., Blair, J., and Zhang, H. (2001). The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E. Biochem. Biophys. Res. Commun. 281, 884-890.
43. Yokoi, S., Yasui, K., Iizasa, T., Takahashi, T., Fujisawa, T., and Inazawa, J. (2003). Down-regulation of SKP2 induces apoptosis in lung-cancer cells. Cancer Sci. 94, 344-349.
44. Zhang, C., Zhang, F., Tsan, R., and Fidler, I. (2009). Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain. Cancer Res. 69, 828-835.
45. Zheng, N., Schulman, B.A., Song, L. et al. (2002). Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 416, 703-709.
46. Zhu, C.Q., Blackhall, F.H., Pintilie, M. et al. (2004). Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker. Clin. Cancer Res. 10, 1984-1991.
47. Zieve, G.W., Turnbull, D., Mullins, J.M., McIntosh, J.R. (1980). Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Nocodazole accumulated mitotic cells. Exp. Cell Res. 126, 397-405.